acute myocardial infarction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients aged 18~80 years; 2.the onset of acute myocardial infarction within 24 hours;3.Signed informed consent for the study
Exclusion criteria
Exclusion criteria: Patients with malignant disease, other actute or chronic inflammatory disease, cardiogenic shock or cardiac arrest occurs before study, serious liver and kidney dysfunction, treatment with anti-inflammatory drugs such as non-steroidal anti-inflammatory drugs and steroids, pregnant women, the Other disease having clinical significance respiratory, digestive, blood, infection, immunization, endocrine, neurological or the disease may cause serious risk dissection, participating in other clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| T cell (including Th1, Th2, Th17, Th22, and Treg);plasma markers (lipid and lipoprotein fractions, fasting glucose);C-reactive protein (CRP);NT-proBNP;cytokines such as IL-6;Coronary angiography;Cardiac ultrasound examination and image analysis;ECG;T cell related cytokines (including IFN-?, IL-4 and so on); | — |
Countries
China
Contacts
Department of Cardiology, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China